Aurora Cannabis (ACB) Cash from Investing Activities (2017 - 2025)

Aurora Cannabis (ACB) reported Cash from Investing Activities of -$3.6 million for Q1 2025, down 17.75% year-over-year from -$4.4 million in Q1 2024, and down 56.31% quarter-over-quarter from -$2.3 million in Q4 2024.

Aurora Cannabis (ACB) Cash from Investing Activities (2017 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has 9 years of Cash from Investing Activities data on file, last reported at -$3.6 million in Q1 2025.

  • Cash from Investing Activities for Q1 2025 came in at -$3.6 million, down 17.75% year-over-year; the trailing twelve-month figure through Mar 2025 was -$8.6 million (down 188.16% YoY), and the FY2025 annual result was -$10.9 million, down 336.15% from the prior year.
  • Cash from Investing Activities retreated to -$3.6 million in Q1 2025 per ACB's latest filing, from -$2.3 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $25.8 million in Q4 2021 and troughed at -$33.3 million in Q3 2021.
  • A 5-year average of -$4.2 million and a median of -$2.7 million in 2024 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities jumped 770.37% in 2021, then sank 324.38% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at $25.8 million in 2021, then plunged by 58.66% to $10.7 million in 2022, then tumbled by 52.65% to $5.1 million in 2023, then tumbled by 145.45% to -$2.3 million in 2024, then slumped by 56.31% to -$3.6 million in 2025.
  • Business Quant data shows ACB's Cash from Investing Activities at -$3.6 million in Q1 2025, -$2.3 million in Q4 2024, and -$2.7 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn -2.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2025 -3.59 Mn
Mar 31, 2025 -3.59 Mn
Dec 31, 2024 -2.30 Mn
Dec 31, 2024 -2.30 Mn
Sep 30, 2024 -2.67 Mn
Sep 30, 2024 -2.67 Mn
Jun 30, 2024 -11,698.25
Jun 30, 2024 -11,698.25
Mar 31, 2024 -3.05 Mn
Mar 31, 2024 -3.05 Mn
Dec 31, 2023 5.06 Mn
Dec 31, 2023 5.06 Mn
Sep 30, 2023 -2.97 Mn
Sep 30, 2023 -2.97 Mn
Dec 31, 2022 10.68 Mn
Dec 31, 2022 10.68 Mn
Sep 30, 2022 -32.15 Mn
Sep 30, 2022 -32.15 Mn
Jun 30, 2022 -31.17 Mn
Jun 30, 2022 -31.17 Mn